Clinical and economic impact of the taurolidine lock on home parenteral nutrition
Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI.
Main Authors: | , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Grupo Arán
2018
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0212-16112018000800003 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0212-161120180008000032021-04-21Clinical and economic impact of the taurolidine lock on home parenteral nutritionArnoriaga Rodríguez,MaríaPérez de Ciriza Cordeu,MaiteCamblor Álvarez,MiguelBretón Lesmes,IreneMotilla de la Cámara,MartaVelasco Gimeno,CristinaArhip,LoredanaGarcía Peris,PilarCuerda Compés,Cristina Taurolidine Home parenteral nutrition (HPN) Central venous catheter (CVC) Catheter-related bloodstream infection (CRBSI) Costs Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI.Grupo AránNutrición Hospitalaria v.35 n.4 20182018-08-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Arnoriaga Rodríguez,María Pérez de Ciriza Cordeu,Maite Camblor Álvarez,Miguel Bretón Lesmes,Irene Motilla de la Cámara,Marta Velasco Gimeno,Cristina Arhip,Loredana García Peris,Pilar Cuerda Compés,Cristina |
spellingShingle |
Arnoriaga Rodríguez,María Pérez de Ciriza Cordeu,Maite Camblor Álvarez,Miguel Bretón Lesmes,Irene Motilla de la Cámara,Marta Velasco Gimeno,Cristina Arhip,Loredana García Peris,Pilar Cuerda Compés,Cristina Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
author_facet |
Arnoriaga Rodríguez,María Pérez de Ciriza Cordeu,Maite Camblor Álvarez,Miguel Bretón Lesmes,Irene Motilla de la Cámara,Marta Velasco Gimeno,Cristina Arhip,Loredana García Peris,Pilar Cuerda Compés,Cristina |
author_sort |
Arnoriaga Rodríguez,María |
title |
Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
title_short |
Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
title_full |
Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
title_fullStr |
Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
title_full_unstemmed |
Clinical and economic impact of the taurolidine lock on home parenteral nutrition |
title_sort |
clinical and economic impact of the taurolidine lock on home parenteral nutrition |
description |
Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI. |
publisher |
Grupo Arán |
publishDate |
2018 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003 |
work_keys_str_mv |
AT arnoriagarodriguezmaria clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT perezdecirizacordeumaite clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT cambloralvarezmiguel clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT bretonlesmesirene clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT motilladelacamaramarta clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT velascogimenocristina clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT arhiploredana clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT garciaperispilar clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition AT cuerdacompescristina clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition |
_version_ |
1755936997469323264 |